These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 3710632

  • 1. Study of bioavailability and pharmacokinetics of theophylline following administration of two sustained release dosage forms as assessed by salivary data: Part II.
    Ohmori N, Inotsume N, Matsukura M, Higashi A, Iwaoku R, Tobino Y, Nakano M, Matsuda I.
    Int J Clin Pharmacol Ther Toxicol; 1986 Apr; 24(4):196-201. PubMed ID: 3710632
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Bioavailability of 3 theophylline delayed-release preparations. Comparison of theophylline concentrations in the serum and saliva in the steady state].
    Bochsler HP, Meyer UA.
    Schweiz Med Wochenschr; 1982 Nov 20; 112(47):1702-10. PubMed ID: 7178872
    [Abstract] [Full Text] [Related]

  • 5. Absorption of theophylline from conventional and sustained-release tablets.
    Fagerström PO, Mellstrand T, Svedmyr N.
    Int J Clin Pharmacol Ther Toxicol; 1981 Mar 20; 19(3):131-8. PubMed ID: 7228455
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Absorption of theophylline from a sustained-release theophylline tablet formulation, Theo-Dur.
    Takagi K, Hasegawa T, Ogura Y, Yamaki K, Suzuki R, Satake T, Imaeda N, Mizukami Y.
    Int J Clin Pharmacol Ther Toxicol; 1987 Oct 20; 25(10):530-5. PubMed ID: 3429057
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Absorption of theophylline from conventional and sustained-release tablets.
    Mellstrand T, Svedmyr N, Fagerström PO.
    Eur J Respir Dis Suppl; 1980 Oct 20; 109():54-60. PubMed ID: 6934088
    [Abstract] [Full Text] [Related]

  • 12. Bioavailability of sustained-release theophylline formulations.
    Bonora Regazzi M, Rondanelli R, Vidale E, Cristiani D.
    Int J Clin Pharmacol Ther Toxicol; 1983 May 20; 21(5):245-51. PubMed ID: 6862729
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T, Kanbe H, Okada M, Kawase I, Ikeda Y, Onuki Y, Kaneko T, Sonobe T.
    Int J Pharm; 2007 Aug 16; 341(1-2):105-13. PubMed ID: 17512147
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Bioavailability of theophylline in a new oral sustained-release preparation (author's transl)].
    Schneider GF, Heese GU, Huber HJ, Janzen N, Jünger H, Moser C, Stanislaus F.
    Arzneimittelforschung; 1981 Aug 16; 31(9):1489-97. PubMed ID: 7197962
    [Abstract] [Full Text] [Related]

  • 19. The absolute bioavailability of a new pediatric sustained release theophylline tablet, when given as whole or divided tablets.
    Jonkman JH, van der Boon WJ, Schoenmaker R, Holtkamp A, Thürkow-Luikens AJ.
    Int J Clin Pharmacol Ther Toxicol; 1984 Sep 16; 22(9):506-10. PubMed ID: 6500770
    [Abstract] [Full Text] [Related]

  • 20. Effect of sustained-release on the pharmacokinetics of theophylline in healthy subjects.
    Bialer M, Salame K, Raz I.
    Int J Clin Pharmacol Ther Toxicol; 1985 Dec 16; 23(12):662-7. PubMed ID: 4093206
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.